MedImmune LLC
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://medimmune.com
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children
- Conditions
- Influenza
- Interventions
- Biological: FluMistOther: Placebo
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-02-08
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 1200
- Registration Number
- NCT00192491
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
- Conditions
- Influenza
- Interventions
- Biological: FluMist
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2007-12-28
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 345
- Registration Number
- NCT00192140
- Locations
- ๐บ๐ธ
SFBC International, Inc, Miami, Florida, United States
๐บ๐ธChildren's Memorial Hospital, Chicago, Illinois, United States
๐บ๐ธKentucky Pediatric / Adult Research, Inc, Bardstown, Kentucky, United States
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants
- Conditions
- Healthy
- Interventions
- Biological: CAIV-TBiological: FluMistBiological: CAIVT
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2007-11-27
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 890
- Registration Number
- NCT00192335
- Locations
- ๐บ๐ธ
Heart of America Research Institute, Shawnee Mission, Kansas, United States
๐บ๐ธKentucky Pediatric/Adult Research, Inc., Bardstown, Kentucky, United States
๐บ๐ธR/D Clinical Research, Inc., Lake Jackson, Texas, United States
Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk
- Conditions
- Severe Respiratory Disease
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2007-05-07
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 1500
- Registration Number
- NCT00192439
- Locations
- ๐บ๐ธ
Miller Children's Hospital, Long Beach, California, United States
๐บ๐ธThe Children's Hospital, Buffalo, New York, United States
๐บ๐ธChildren's Memorial Hospital, Chicago, Illinois, United States
Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis
- Conditions
- Psoriasis
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-25
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 120
- Registration Number
- NCT00192452
- Locations
- ๐บ๐ธ
MDS Pharma Services (US) Inc., Phoenix, Arizona, United States
๐บ๐ธWake Forest University School of Medicine, Winston-Salem, North Carolina, United States
๐บ๐ธNorthwest Kinetics, Tacoma, Washington, United States
Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult Volunteers
- Conditions
- Asthma
- Interventions
- Biological: MEDI-528 3 mg/kgBiological: MEDI-528 9 mg/kgBiological: MEDI-528 1 mg/kgBiological: MEDI-528 0.3 mg/kg
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 24
- Registration Number
- NCT00192296
- Locations
- ๐บ๐ธ
MDS Pharma Services, New Orleans, Louisiana, United States
Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)
- Conditions
- Influenza
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-25
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 200
- Registration Number
- NCT00192361
- Locations
- ๐ซ๐ฎ
Kauppakatu Clinic, Tampere, Finland
Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.
- Conditions
- Healthy
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 2160
- Registration Number
- NCT00192400
Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma
- Conditions
- Asthma
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 2229
- Registration Number
- NCT00192257
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children
- Conditions
- Healthy
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 3000
- Registration Number
- NCT00192244
- Locations
- ๐จ๐ณ
The Prince of Wales Hospital, Hong Kong, China